Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - OTHER CURRENT LIABILITIES
Other Current Liabilities YMAB - Y-mAbs Therapeutics, Inc.
16.4 M
LAST VALUE
15.15%
2 YEAR CAGR
32.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR